Example of Frontiers in Pharmacology format
Recent searches

Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format Example of Frontiers in Pharmacology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Frontiers in Pharmacology — Template for authors

Publisher: Frontiers Media
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #45 of 246 up up by 23 ranks
Pharmacology #72 of 297 up up by 36 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 5929 Published Papers | 36808 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 19/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 6.1
SJR: 1.333
SNIP: 1.061
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646
open access Open Access
recommended Recommended

American Society for Microbiology

Quality:  
High
CiteRatio: 9.1
SJR: 2.07
SNIP: 1.44
open access Open Access
recommended Recommended

Bentham Science

Quality:  
High
CiteRatio: 10.5
SJR: 1.955
SNIP: 1.851

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

6.2

24% from 2019

CiteRatio for Frontiers in Pharmacology from 2016 - 2020
Year Value
2020 6.2
2019 5.0
2018 3.9
2017 4.7
2016 5.1
graph view Graph view
table view Table view

1.384

13% from 2019

SJR for Frontiers in Pharmacology from 2016 - 2020
Year Value
2020 1.384
2019 1.228
2018 1.256
2017 1.587
2016 1.729
graph view Graph view
table view Table view

1.38

15% from 2019

SNIP for Frontiers in Pharmacology from 2016 - 2020
Year Value
2020 1.38
2019 1.197
2018 1.053
2017 1.145
2016 1.097
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 24% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 13% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 15% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Frontiers in Pharmacology

Guideline source: View

Potential, possible, or probable predatory scholarly open-access publishers.

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Frontiers Media

Frontiers in Pharmacology

Approved by publishing and review experts on SciSpace, this template is built as per for Frontiers in Pharmacology formatting guidelines as mentioned in Frontiers Media author instructions. The current version was created on 18 Jun 2020 and has been used by 722 authors to write and format their manuscripts to this journal.

Pharmacology (medical)

Medicine

i
Last updated on
18 Jun 2020
i
ISSN
1663-9812
i
Impact Factor
Medium - 0.8
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
frontiersinSCNS_ENG_HUMS
i
Citation Type
Author Year
(25)
i
Bibliography Example
Beenakker, C. W. J. (2006). Specular andreev reflection in graphene. Phys. Rev. Lett. 97, 067007

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.3389/FPHAR.2013.00177
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
Martins Ekor1

Abstract:

The use of herbal medicinal products and supplements has increased tremendously over the past three decades with not less than 80% of people worldwide relying on them for some part of primary health care. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal prod... The use of herbal medicinal products and supplements has increased tremendously over the past three decades with not less than 80% of people worldwide relying on them for some part of primary health care. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal products clearly established, many of them remain untested and their use are either poorly monitored or not even monitored at all. The consequence of this is an inadequate knowledge of their mode of action, potential adverse reactions, contraindications and interactions with existing orthodox pharmaceuticals and functional foods to promote both safe and rational use of these agents. Since safety continues to be a major issue with the use of herbal remedies, it becomes imperative, therefore, that relevant regulatory authorities put in place appropriate measures to protect public health by ensuring that all herbal medicines are safe and of suitable quality. This review discusses toxicity related-issues and major safety concerns arising from the use of herbal medicinal products and also highlights some important challenges associated with effective monitoring of their safety. read more read less
View PDF
2,007 Citations
open accessOpen access Journal Article DOI: 10.3389/FPHAR.2015.00286
Advances and Challenges of Liposome Assisted Drug Delivery.
Lisa Sercombe1, Tejaswi Veerati2, Tejaswi Veerati3, Fatemeh Moheimani1, Sherry Y. Wu2, Anil K. Sood2, Susan Hua1

Abstract:

The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effecti... The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effective delivery of encapsulated compounds to target sites while minimizing systemic toxicity. Liposomes present as an attractive delivery system due to their flexible physicochemical and biophysical properties, which allow easy manipulation to address different delivery considerations. Despite considerable research in the last 50 years and the plethora of positive results in preclinical studies, the clinical translation of liposome assisted drug delivery platforms has progressed incrementally. In this review, we will discuss the advances in liposome assisted drug delivery, biological challenges that still remain, and current clinical and experimental use of liposomes for biomedical applications. The translational obstacles of liposomal technology will also be presented. read more read less

Topics:

Targeted drug delivery (62%)62% related to the paper, Drug delivery (58%)58% related to the paper
View PDF
1,573 Citations
open accessOpen access Journal Article DOI: 10.3389/FPHAR.2017.00561
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.

Abstract:

Several cancers are highly refractory to conventional chemotherapy. The survival of tumors in several cases is assisted by checkpoint immunomodulation to maintain the imbalance between immune surveillance and cancer cell proliferation. Check point antibody inhibitors, such as anti-PD-1/PD-L1, are a novel class of inhibitors t... Several cancers are highly refractory to conventional chemotherapy. The survival of tumors in several cases is assisted by checkpoint immunomodulation to maintain the imbalance between immune surveillance and cancer cell proliferation. Check point antibody inhibitors, such as anti-PD-1/PD-L1, are a novel class of inhibitors that function as a tumor suppressing factor via modulation of immune cell-tumor cell interaction. These checkpoint blockers are rapidly becoming a highly promising cancer therapeutic approach that yields remarkable antitumor responses with limited side effects. In recent times, more than four check point antibody inhibitors have been commercialized for targeting PD-1, PDL-1, and CTLA-4. Despite the huge success and efficacy of the anti-PD therapy response, it is limited to specific types of cancers, which attributes to the insufficient and heterogeneous expression of PD-1 in the tumor microenvironment. Herein, we review the current landscape of the PD-1/PD-L1 mechanistic role in tumor immune evasion and therapeutic outcome for cancer treatment. We also review the current progress in clinical trials, combination of drug therapy with immunotherapy, safety, and future of check point inhibitors for multiple types of cancer. read more read less

Topics:

Atezolizumab (58%)58% related to the paper, Pembrolizumab (57%)57% related to the paper, Cancer (56%)56% related to the paper, Nivolumab (56%)56% related to the paper, Cancer immunotherapy (56%)56% related to the paper
1,163 Citations
open accessOpen access Journal Article DOI: 10.3389/FPHAR.2018.00006
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.
Sigrid A. Langhans1

Abstract:

Drug development is a lengthy and costly process that proceeds through several stages from target identification to lead discovery and optimization, preclinical validation and clinical trials culminating in approval for clinical use. An important step in this process is high-throughput screening (HTS) of small compound librar... Drug development is a lengthy and costly process that proceeds through several stages from target identification to lead discovery and optimization, preclinical validation and clinical trials culminating in approval for clinical use. An important step in this process is high-throughput screening (HTS) of small compound libraries for lead identification. Currently, the majority of cell-based HTS is being carried out on cultured cells propagated in two-dimensions (2D) on plastic surfaces optimized for tissue culture. At the same time, compelling evidence suggests that cells cultured in these non-physiological conditions are not representative of cells residing in the complex microenvironment of a tissue. This discrepancy is thought to be a significant contributor to the high failure rate in drug discovery, where only a low percentage of drugs investigated ever make it through the gamut of testing and approval to the market. Thus, three-dimensional (3D) cell culture technologies that more closely resemble in vivo cell environments are now being pursued with intensity as they are expected to accommodate better precision in drug discovery. Here we will review common approaches to 3D culture, discuss the significance of 3D cultures in drug resistance and drug repositioning and address some of the challenges of applying 3D cell cultures to high-throughput drug discovery. read more read less

Topics:

Drug development (67%)67% related to the paper, Drug repositioning (58%)58% related to the paper, Drug discovery (55%)55% related to the paper
View PDF
911 Citations
open accessOpen access Journal Article DOI: 10.3389/FPHAR.2014.00123
Fibroblasts in fibrosis: novel roles and mediators
Ryan T. Kendall1, Carol Feghali-Bostwick1

Abstract:

Fibroblasts are the most common cell type of the connective tissues found throughout the body and the principal source of the extensive extracellular matrix (ECM) characteristic of these tissues. They are also the central mediators of the pathological fibrotic accumulation of ECM and the cellular proliferation and differentia... Fibroblasts are the most common cell type of the connective tissues found throughout the body and the principal source of the extensive extracellular matrix (ECM) characteristic of these tissues. They are also the central mediators of the pathological fibrotic accumulation of ECM and the cellular proliferation and differentiation that occurs in response to prolonged tissue injury and chronic inflammation. The transformation of the fibroblast cell lineage involves classical developmental signaling programs and includes a surprisingly diverse range of precursor cell types—most notably, myofibroblasts that are the apex of the fibrotic phenotype. Myofibroblasts display exaggerated ECM production; constitutively secrete and are hypersensitive to chemical signals such as cytokines, chemokines, and growth factors; and are endowed with a contractile apparatus allowing them to manipulate the ECM fibers physically to close open wounds. In addition to ECM production, fibroblasts have multiple concomitant biological roles, such as in wound healing, inflammation, and angiogenesis, which are each interwoven with the process of fibrosis. We now recognize many common fibroblast-related features across various physiological and pathological protracted processes. Indeed, a new appreciation has emerged for the role of noncancerous fibroblast interactions with tumors in cancer progression. Although the predominant current clinical treatments of fibrosis involve nonspecific immunosuppressive and anti-proliferative drugs, a variety of potential therapies under investigation specifically target fibroblast biology. read more read less

Topics:

Extracellular matrix (57%)57% related to the paper, Fibrosis (56%)56% related to the paper, Fibroblast (55%)55% related to the paper, Myofibroblast (52%)52% related to the paper, Wound healing (52%)52% related to the paper
View PDF
734 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Frontiers in Pharmacology.

It automatically formats your research paper to Frontiers Media formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Frontiers in Pharmacology format uses frontiersinSCNS_ENG_HUMS citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Frontiers in Pharmacology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Frontiers in Pharmacology guidelines and auto format it.

2. Do you follow the Frontiers in Pharmacology guidelines?

Yes, the template is compliant with the Frontiers in Pharmacology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Frontiers in Pharmacology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Frontiers in Pharmacology citation style.

4. Can I use the Frontiers in Pharmacology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Frontiers in Pharmacology.

5. Can I use a manuscript in Frontiers in Pharmacology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Frontiers in Pharmacology that you can download at the end.

6. How long does it usually take you to format my papers in Frontiers in Pharmacology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Frontiers in Pharmacology.

7. Where can I find the template for the Frontiers in Pharmacology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Frontiers in Pharmacology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Frontiers in Pharmacology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Frontiers in Pharmacology an online tool or is there a desktop version?

SciSpace's Frontiers in Pharmacology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Frontiers in Pharmacology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Frontiers in Pharmacology?”

11. What is the output that I would get after using Frontiers in Pharmacology?

After writing your paper autoformatting in Frontiers in Pharmacology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Frontiers in Pharmacology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Frontiers in Pharmacology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Frontiers in Pharmacology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Frontiers in Pharmacology?

The 5 most common citation types in order of usage for Frontiers in Pharmacology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Frontiers in Pharmacology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Frontiers in Pharmacology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Frontiers in Pharmacology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Frontiers in Pharmacology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Frontiers in Pharmacology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template